Plant ID: NPO21343
Plant Latin Name: Eupatorium fortunei
Taxonomy Genus: Eupatorium
Taxonomy Family: Asteraceae
NCBI TaxonomyDB:
330892
Plant-of-the-World-Online:
205930-1
South Africa; Japan; India; Vietnam; China; Laos; Thailand
TRPA1; | |
CA2; CA1; | |
PTGS1; | |
ALDH1A1; | |
LMNA; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 2 | CYP2A6 | Cytochrome P450 2A6 | P11509 | CHEMBL5282 |
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P00352 | CHEMBL3577 |
Lyase | CA2 | Carbonic anhydrase II | P00918 | CHEMBL205 |
Lyase | CA1 | Carbonic anhydrase I | P00915 | CHEMBL261 |
Oxidoreductase | PTGS1 | Cyclooxygenase-1 | P23219 | CHEMBL221 |
Transient receptor potential channel | TRPA1 | Transient receptor potential cation channel subfamily A member 1 | O75762 | CHEMBL6007 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0003824; catalytic activity | GO:0004064; arylesterase activity | 2.250E-06 | 4.899E-02 | CA1, CA2 |
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 9.886E-06 | 6.845E-02 | CYP2A6, CYP3A4 |
MF | GO:0005488; binding | GO:0020037; heme binding | 1.554E-05 | 6.845E-02 | CYP2A6, CYP3A4, PTGS1 |
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 1.572E-05 | 6.845E-02 | CA1, CA2 |
MF | GO:0003824; catalytic activity | GO:0016712; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 4.854E-05 | 1.174E-01 | CYP2A6, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0008395; steroid hydroxylase activity | 8.365E-05 | 1.821E-01 | CYP2A6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 9.390E-05 | 1.859E-01 | CA1, CA2 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 1.408E-04 | 2.358E-01 | CA1, CA2 |
BP | GO:0008152; metabolic process | GO:0019369; arachidonic acid metabolic process | 2.125E-04 | 3.200E-01 | CYP2A6, PTGS1 |
BP | GO:0008152; metabolic process | GO:0055114; oxidation-reduction process | 2.795E-04 | 3.758E-01 | ALDH1A1, CYP2A6, CYP3A4, PTGS1 |
BP | GO:0008152; metabolic process | GO:0044255; cellular lipid metabolic process | 3.716E-04 | 3.758E-01 | ALDH1A1, CYP2A6, CYP3A4, PTGS1 |
CC | GO:0044464; cell part | GO:0032421; stereocilium bundle | 2.069E-03 | 6.008E-01 | TRPA1 |
CC | GO:0016020; membrane | GO:0005789; endoplasmic reticulum membrane | 5.052E-03 | 1.000E+00 | CYP2A6, CYP3A4, PTGS1 |
CC | GO:0016020; membrane | GO:0031090; organelle membrane | 1.702E-02 | 1.000E+00 | CYP2A6, CYP3A4, LMNA, PTGS1 |
CC | GO:0044421; extracellular region part | GO:0070062; extracellular exosome | 1.917E-02 | 1.000E+00 | ALDH1A1, CA1, CA2, PTGS1 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 1.814E-06 | 4.353E-05 | CYP2A6, ALDH1A1, CYP3A4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00983 | Drug metabolism - other enzymes | 1.436E-04 | 1.149E-03 | CYP2A6, CYP3A4 |
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 1.898E-05 | 2.278E-04 | CA1, CA2 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 3.241E-04 | 1.451E-03 | CYP2A6, CYP3A4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 3.627E-04 | 1.451E-03 | CYP2A6, CYP3A4 |
09150 Organismal Systems | 09154 Digestive system | hsa04976 | Bile secretion | 3.431E-04 | 1.451E-03 | CA2, CYP3A4 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 8.386E-04 | 2.516E-03 | CYP2A6, ALDH1A1, CYP3A4, PTGS1 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 4.576E-04 | 1.569E-03 | CYP2A6, CYP3A4 |
09150 Organismal Systems | 09155 Excretory system | hsa04964 | Proximal tubule bicarbonate reclamation | 9.165E-03 | 2.200E-02 | CA2 |
09100 Metabolism | 09110 Biosynthesis of other secondary metabolites | hsa00232 | Caffeine metabolism | 1.999E-03 | 5.330E-03 | CYP2A6 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|